Deep reinforcement learning enabled by AI can help physicians figure out whether opioids would truly be better than other interventions for patients suffering pain in intensive care units.

Plastic surgeons can apply “emotional AI” algorithms to social media as a way of predicting which specific services will bring in business, according to a study running in the August edition of Plastic and Reconstructive Surgery.

“For radiologists, who generally perform routine activities, involvement in clinical trials increases their workload and raises human resources issues at hospitals which are already running chronic medical deficits,” wrote authors of a new study published in the European Journal of Radiology.

Swiss drugmaker Novartis on July 29 announced its combo sacubitril/valsartan drug Entresto “narrowly missed” its primary endpoint in the Phase III PARAGON-HF study, throwing into question the future of a blockbuster drug.

Seemingly innocuous web browser extensions are actually a gateway for health and other data to be collected––and even put up for sale, according to Geoffrey Fowler, technology columnist for The Washington Post.

Medications used to treat atrial fibrillation—namely amiodarone—could increase older patients’ risk of fainting and falling, Danish researchers have found.

Pfizer, one of the nation’s largest pharmaceutical companies, is merging its off-patent and generic drug business with Mylan, a global generic and specialty pharmaceutical company based in the Netherlands. The spinoff deal is expected to close mid-2020, pending shareholder and regulatory approvals.

Boone County Health Center in Albion, Nebraska, first opened back in 1950, ensuring that patients from the seven rural counties it serves could receive care without making the long drive to Lincoln or Omaha. 

A deep learning platform can accurately distinguish critical from non-critical feeding tube placement on radiographs, according to a recent study published in the Journal of Digital Imaging.

Progenics Pharmaceuticals, a New York City-based oncology and imaging company, has announced a new collaboration aimed at improving care for veterans with prostate cancer.